Drug Type Small molecule drug |
Synonyms Cytolytic thioxanthone, Thioxanthone, BCN 326862 + [5] |
Target |
Action inhibitors |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H27N3O3S |
InChIKeyGWLFIMOOGVXSMZ-UHFFFAOYSA-N |
CAS Registry155990-20-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Leukemia | Phase 1 | France | - | |
| Leukemia | Phase 1 | - | - | |
| Lymphoma | Phase 1 | France | - | |
| Lymphoma | Phase 1 | - | - | |
| Solid tumor | Phase 1 | Europe | - |
ASCO2005 Manual | Phase 1 | 31 | smpdbkkrwq(gurheyalfs) = mqnywqwdiy pvpgnbdmig (vhiuekfxoz ) | Not Applicable | 01 Jun 2005 | ||
Phase 1 | 18 | dlxijnadbt(xfclrvauek) = oigqrdmwjr rynjmsolqj (whufuwcqbh ) | - | 01 Jun 2005 | |||
Phase 1 | 17 | kbyheewicm(ofdqtihqgx) = tmevtzakqb cctzdfmedw (wgoijbiruy ) | - | 01 Jun 2005 |





